Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
44,847,024
-
Share change
-
-1,220,521
-
Total reported value
-
$2,984,022,064
-
Put/Call ratio
-
180%
-
Price per share
-
$66.43
-
Number of holders
-
184
-
Value change
-
-$95,572,561
-
Number of buys
-
87
-
Number of sells
-
82
Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q3 2021
As of 30 Sep 2021,
TURNING POINT THERAPEUTICS I - COM (TPTX) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,847,024 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, FMR LLC, STATE STREET CORP, FEDERATED HERMES, INC., and ALLIANCEBERNSTEIN L.P..
This page lists
184
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.